PRTN3 and COVID-19: Although there was no meaningful difference between patients and controls in terms of antiphospholipid (IgG), the occurrence of ANAs, anti‐dsDNA, anti‐CCP, c‐ANCA, and p‐ANCA were significantly higher in the COVID‐19 patients compared to serum obtained from healthy subjects (p < .0001, p < .0001, p < .0001, p = .03, and p < .001, respectively) (Table 1).